A phase I/II multicenter, open-label, dose escalation and randomized trial of BI 836858 in patients with low- or intermediate-1-risk myelodysplastic syndrome

Bibliographic Details
Published in:	Haematologica
Main Authors:	Rami S. Komrokji, Hetty E. Carraway, Ulrich Germing, Martin Wermke, Amer M. Zeidan, Eric Fu, Björn Rüter, Ute Burkard, Annika Osswald, James M. Foran
Format:	Article
Language:	English
Published:	Ferrata Storti Foundation 2022-06-01
Online Access:	https://haematologica.org/article/view/10683

Internet